Enhancement of glycogen concentrations in primary cultures of rat hepatocytes exposed to glucose and fructose.

Por Parniak, M A, Kalant, N
Publicado em 1988

Non-enzymic glycation of collagen inhibits binding of oxidized low-density lipoprotein.

Por Kalant, N, McCormick, S, Parniak, M A
Publicado em 1993

Interaction with a monoclonal antibody alters the expression of co-operativity by phenylalanine hydroxylase from rat liver.

Por Parniak, M A, Jennings, I G, Cotton, R G
Publicado em 1989

Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2',3'-dideoxycytidine 5'-triphosphate an...

Por Gu, Z, Arts, E J, Parniak, M A, Wainberg, M A
Publicado em 1995

Studies of neutralizing monoclonal antibody to human immunodeficiency virus type 1 reverse transcriptase: antagonistic and synergistic effects in reactions performed in the presenc...

Por Gu, Z, Li, X, Quan, Y, Parniak, M A, Wainberg, M A
Publicado em 1996

Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine.

Por Gu, Z, Gao, Q, Li, X, Parniak, M A, Wainberg, M A
Publicado em 1992

Mutational analysis of Lys65 of HIV-1 reverse transcriptase.

Por Sluis-Cremer, N, Arion, D, Kaushik, N, Lim, H, Parniak, M A
Publicado em 2000

Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcrip...

Por Borkow, G, Barnard, J, Nguyen, T M, Belmonte, A, Wainberg, M A, Parniak, M A
Publicado em 1997

In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.

Por Gao, Q, Gu, Z X, Parniak, M A, Li, X G, Wainberg, M A
Publicado em 1992

The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) e...

Por Gao, Q, Gu, Z, Parniak, M A, Cameron, J, Cammack, N, Boucher, C, Wainberg, M A
Publicado em 1993

Effect of mutations in the nucleocapsid protein (NCp7) upon Pr160(gag-pol) and tRNA(Lys) incorporation into human immunodeficiency virus type 1.

Por Huang, Y, Khorchid, A, Wang, J, Parniak, M A, Darlix, J L, Wainberg, M A, Kleiman, L
Publicado em 1997

Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication.

Por Li, X, Mak, J, Arts, E J, Gu, Z, Kleiman, L, Wainberg, M A, Parniak, M A
Publicado em 1994

Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1.

Por Li, X, Liang, C, Quan, Y, Chandok, R, Laughrea, M, Parniak, M A, Kleiman, L, Wainberg, M A
Publicado em 1997

Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-...

Por Gu, Z, Gao, Q, Fang, H, Salomon, H, Parniak, M A, Goldberg, E, Cameron, J, Wainberg, M A
Publicado em 1994

Biological comparison of wild-type and zidovudine-resistant isolates of human immunodeficiency virus type 1 from the same subjects: susceptibility and resistance to other drugs.

Por Rooke, R, Parniak, M A, Tremblay, M, Soudeyns, H, Li, X G, Gao, Q, Yao, X J, Wainberg, M A
Publicado em 1991

Preclinical Safety Assessments of UC781 Anti-Human Immunodeficiency Virus Topical Microbicide Formulations

Por Patton, D. L., Sweeney, Y. T. Cosgrove, Balkus, J. E., Rohan, L. C., Moncla, B. J., Parniak, M. A., Hillier, S. L.
Publicado em 2007

Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline...

Por Pelemans, H, Esnouf, R, Dunkler, A, Parniak, M A, Vandamme, A M, Karlsson, A, De Clercq, E, Kleim, J P, Balzarini, J
Publicado em 1997

THE SUGAR RING CONFORMATION OF 4’-ETHYNYL-2-FLUORO-2’-DEOXYADENOSINE AND ITS RECOGNITION BY THE POLYMERASE ACTIVE SITE OF HIV REVERSE TRANSCRIPTASE

Por Kirby, K.A., Singh, K., Michailidis, E., Marchand, B., Kodama, E.N., Ashida, N., Mitsuya, H., Parniak, M.A., Sarafianos, S.G.
Publicado em 2011

EFFECT OF TRANSLOCATION DEFECTIVE REVERSE TRANSCRIPTASE INHIBITORS ON THE ACTIVITY OF N348I, A CONNECTION SUBDOMAIN DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE MUTANT

Por MICHAILIDIS, E., SINGH, K., RYAN, E.M., HACHIYA, A., ONG, Y.T., KIRBY, K.A., MARCHAND, B., KODAMA, E.N., MITSUYA, H., PARNIAK, M.A., SARAFIANOS, S.G.
Publicado em 2012

Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA...

Por Li, X, Quan, Y, Arts, E J, Li, Z, Preston, B D, de Rocquigny, H, Roques, B P, Darlix, J L, Kleiman, L, Parniak, M A, Wainberg, M A
Publicado em 1996